Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim + Ciclosporin A in Untreated Aplastic Anemia
NCT04095936Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Dec 2019
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of romiplostim in aplastic anemia, sponsored by Kyowa Kirin. Started Dec 2019; status: completed.
02
Drugs
romiplostim
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT04095936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04095936.